Drupal.behaviors.print = function(context) {window.print();window.close();}>

Sloan-Kettering Scientists Using Cancer Drug Candidate to Study Aberrant Protein Pathways

September 30, 2011

Sloan-Kettering Scientists Using Cancer Drug Candidate to Study Aberrant Protein Pathways

 

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories